MyFinsight
Home
Blog
About
Net gain applicable
to common...
-$2,867,303
(-6.16%↓ Y/Y)
Net gain
-$2,867,303
(-20.86%↓ Y/Y)
CH
$10,322
GB
$6,798
Gain before income
taxes
-$2,867,303
(-20.86%↓ Y/Y)
Revenue
$17,120
(-83.92%↓ Y/Y)
Loss from operations
-$2,730,790
(-41.10%↓ Y/Y)
Total other income
(loss)
-$136,513
(68.76%↑ Y/Y)
Gross profit
$4,303
(-93.90%↓ Y/Y)
Other income (loss)
$4,747
(120.95%↑ Y/Y)
Cost of revenue
$12,817
(-64.39%↓ Y/Y)
Total operating
expenses
$2,735,093
(36.35%↑ Y/Y)
Change in fair value of
series d derivative...
$136,471
Interest expense
$4,389
(-98.03%↓ Y/Y)
Change in fair value of
contingent warrant...
$400
(74.67%↑ Y/Y)
Selling, general, and
administrative
$2,245,653
(47.39%↑ Y/Y)
Impairment of goodwill
$486,000
(-18.18%↓ Y/Y)
Research and development
$3,440
(103.08%↑ Y/Y)
Back
Back
Income Statement
Onconetix, Inc. (ONCO)
Onconetix, Inc. (ONCO)
source: myfinsight.com